The global market for in vitro diagnostics (IVD) is expected to grow significantly, reaching an estimated value of $157.63 billion by 2030. This growth is driven by advancements across various product categories, including diagnostic kits and instruments, as well as technologies such as immunoassays, hematology, and glucose monitoring. Blood remains a primary specimen for testing, with applications spanning endocrinology, cardiology, and infectious diseases.
Market expansion is also influenced by diverse testing sites and increasing demand for accurate, timely diagnostics worldwide. The forecast highlights the importance of innovation and regional developments in shaping the future of the IVD industry.
**Why this matters**
In vitro diagnostics play a crucial role in early disease detection, treatment monitoring, and personalized medicine. The projected market growth reflects rising healthcare needs and technological progress, which together can improve patient outcomes and support healthcare systems globally. Understanding these trends helps stakeholders make informed decisions in healthcare planning and investment.
Source: News Source